AAAAAA
Results: 26-38/38
Authors:
Scheding, S
Franke, H
Diehl, V
Wichmann, HE
Brugger, W
Kanz, L
Schmitz, S
Citation: S. Scheding et al., How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulation, EXP HEMATOL, 27(5), 1999, pp. 956-965
Authors:
Stuhler, G
Zobywalski, A
Grunebach, F
Brossart, P
Reichardt, VL
Barth, H
Stevanovic, S
Brugger, W
Kanz, L
Schlossman, SF
Citation: G. Stuhler et al., Immune regulatory loops determine productive interactions within human T lymphocyte dendritic cell clusters, P NAS US, 96(4), 1999, pp. 1532-1535
Authors:
Schmitz, K
Brugger, W
Weiss, B
Kaiserling, E
Kanz, L
Citation: K. Schmitz et al., Clonal selection of CD20-negative non-Hodgkin's lymphoma cells after treatment with anti-CD20 antibody rituximab, BR J HAEM, 106(2), 1999, pp. 571-572
Authors:
Buhring, HJ
Simmons, PJ
Pudney, M
Muller, R
Jarrossay, D
van Agthoven, A
Willheim, M
Brugger, W
Valent, P
Kanz, L
Citation: Hj. Buhring et al., The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors, BLOOD, 94(7), 1999, pp. 2343-2356
Authors:
Vogel, W
Kanz, L
Brugger, W
Berndt, A
Kosmehl, H
Citation: W. Vogel et al., Expression of laminin beta 2 chain in normal human bone marrow, BLOOD, 94(3), 1999, pp. 1143-1145
Authors:
Buhring, HJ
Seiffert, M
Marxer, A
Weiss, B
Faul, C
Kanz, L
Brugger, W
Citation: Hj. Buhring et al., AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34(+) B-cell precursors, BLOOD, 94(2), 1999, pp. 832-833
Authors:
Brossart, P
Spahlinger, B
Grunebach, F
Stuhler, G
Reichardt, VL
Kanz, L
Brugger, W
Citation: P. Brossart et al., Induction of minor histocompatibility antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation, BLOOD, 94(12), 1999, pp. 4374-4376
Authors:
Seiffert, M
Cant, C
Chen, ZJ
Rappold, I
Brugger, W
Kanz, L
Brown, EJ
Ullrich, A
Buhring, HJ
Citation: M. Seiffert et al., Human signal-regulatory protein is expressed on normal, but not on subsetsof leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47, BLOOD, 94(11), 1999, pp. 3633-3643
Authors:
Archimbaud, E
Ottmann, OG
Yin, JAL
Lechner, K
Dombret, H
Sanz, MA
Heil, G
Fenaux, P
Brugger, W
Barge, A
O'Brien-Ewen, C
Matcham, J
Hoelzer, D
Citation: E. Archimbaud et al., A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia, BLOOD, 94(11), 1999, pp. 3694-3701
Authors:
Brossart, P
Heinrich, KS
Stuhler, G
Behnke, L
Reichardt, VL
Stevanovic, S
Muhm, A
Rammensee, HG
Kanz, L
Brugger, W
Citation: P. Brossart et al., Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies, BLOOD, 93(12), 1999, pp. 4309-4317
Authors:
Scheding, S
Brugger, W
Kanz, L
Citation: S. Scheding et al., Autologous stem cell transplantation and manipulation, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 383-408
Authors:
Bowen, DT
Denzlinger, C
Brugger, W
Culligan, D
Gelly, K
Adlakha, S
Groves, M
Hepburn, M
Kanz, L
Citation: Dt. Bowen et al., Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients, BR J HAEM, 103(3), 1998, pp. 785-787
Authors:
Brugger, W
Citation: W. Brugger, Constitutional law in theory and practice., AM J COMP L, 46(3), 1998, pp. 583-591